Belgium
MRM Health is a biopharmaceutical company focused on redefining microbiome-based therapeutics. Founded in 2020 and based in Ghent, Belgium, the company operates within a Center of Expertise for microbiome research and development in the biotech cluster. MRM Health has established a strategic partnership with the VIB, collaborating with top research groups in microbiome analysis, ecology, host biology, and disease research.
The company boasts support from strong local and international investors including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II, and VIB. Additionally, MRM Health has a corporate collaboration with DuPont Nutrition Biosciences for the development of microbiome-based therapeutics, specifically targeting metabolic diseases.
MRM Health's proprietary technology platform leverages live microbial therapeutics development by combining rationally selected strains into synergistic consortia through a proprietary optimization process. The company's recent Venture Round investment at 07 March 2023 saw participation from SFPIM. By pioneering innovative therapeutics based on the human microbiome, MRM Health is positioned at the forefront of the biotechnology, healthcare, and pharmaceutical industries.
